Shares of Icosavax, Inc. ICVX rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.
Icosavax also reported topline interim Phase 2 results for combination VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults.
Icosavax shares gained 44.8% to $15.19 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Bruush Oral Care Inc. BRSH shares rose 76.8% to $0.2882 in pre-market trading after gaining over 5% on Monday.
- Connect Biopharma Holdings Limited CNTB rose 32.2% to $1.19 in pre-market trading. Connect Biopharma will present top-line data from the global Phase 2b trial evaluating rademikibart’s efficacy and safety in patients with moderate-to-severe asthma on Dec. 12, 2023.
- Kaival Brands Innovations Group, Inc. KAVL shares rose 28% to $0.3159 in pre-market trading. Kaival Brands recently appointed James W. Dobbins as General Counsel.
- IN8bio, Inc.INAB gained 25.8% to $1.61 in pre-market trading after the company announced updated data from its Phase 1 investigator-sponsored trial of INB-100 in patients with hematologic malignancies.
- Avenue Therapeutics, Inc. ATXI gained 21.2% to $0.1649 in pre-market trading after falling 11% on Monday.
- Hanryu Holdings, Inc. HRYU shares surged 16% to $0.73 in pre-market trading after jumping 40% on Monday.
- TeraWulf Inc. WULF shares gained 12% to $1.59 in pre-market trading after falling 22% on Monday.
- Tenax Therapeutics, Inc. TENX shares climbed 10.6% to $0.2999 in pre-market trading.
- Blue Bird Corporation BLBD shares rose 7.3% to $23.40 in pre-market trading after the company reported better-than-expected financial results for its fourth quarter and increased its FY24 revenue forecast.
Losers
- Harbor Custom Development, Inc. HCDI shares fell 18.6% to $0.5538 in pre-market trading. Harbor Custom Development voluntarily filed for protection under Chapter 11 Bankruptcy.
- SRIVARU Holding Limited SVMH fell 17.3% to $0.5958 in pre-market trading after jumping 20% on Monday.
- Achieve Life Sciences, Inc. ACHV shares fell 21.1% to $4.30 in pre-market trading. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline.
- Assure Holdings Corp. IONM shares fell 13.4% to $0.3740 in pre-market trading after climbing over 23% on Monday.
- Clearmind Medicine Inc. CMND fell 13.2% to $2.64 in pre-market trading. Clearmind Medicine filed for mixed shelf of up to $50 million.
- Exicure, Inc. XCUR shares fell 12.2% to $0.5480 in pre-market trading after jumping over 20% on Monday.
- Assembly Biosciences, Inc. ASMB fell 11.1% to $0.6750 in pre-market.
- Onconova Therapeutics, Inc. ONTX shares fell 11% to $0.7034 in pre-market trading after gaining 23% on Monday.
- Hempacco Co., Inc. HPCO shares fell 10.8% to $0.3606 in pre-market trading.
- Oracle Corporation ORCL fell 8.5% to $105.40 in pre-market trading. Oracle reported upbeat earnings for its second quarter, while sales missed estimates.
Now Read This: Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in